Literature DB >> 11927172

From first drug use to drug dependence; developmental periods of risk for dependence upon marijuana, cocaine, and alcohol.

Fernando A Wagner1, James C Anthony.   

Abstract

The focal point of this paper is the transition from drug use to drug dependence. We present new evidence on risk for starting to use marijuana, cocaine, and alcohol, as well as risks for progression from first drug use to the onset of drug dependence, separately for each of these drugs. Data from the National Comorbidity Survey (NCS) were analyzed. The NCS had a representative sample of the United States population ages 15-54 years (n = 8,098). Survival analysis techniques were used to provide age- and time-specific risk estimates of initiating use of marijuana, cocaine, and alcohol, as well as of becoming dependent on each drug. With respect to risk of initiating use, estimated peak values for alcohol and marijuana were found at age 18, about two years earlier than the later peak in risk of initiating cocaine use. With respect to risk of meeting criteria for the clinical dependence syndrome, estimated peak values for alcohol and marijuana were found at age 17-18. Peak values for cocaine dependence were found at age 23-25. Once use began, cocaine dependence emerged early and more explosively, with an estimated 5-6% of cocaine users becoming cocaine dependent in the first year of use. Most of the observed cases of cocaine dependence met criteria for dependence within three years after initial cocaine use. Whereas some 15-16% of cocaine users had developed cocaine dependence within 10 years of first cocaine use, the corresponding values were about 8% for marijuana users, and 12-13% for alcohol users. The most novel findings of this study document a noteworthy risk for quickly developing cocaine dependence after initial cocaine use, with about one in 16 to 20 cocaine users becoming dependent within the first year of cocaine use. For marijuana and alcohol, there is a more insidious onset of the drug dependence syndrome.

Entities:  

Mesh:

Year:  2002        PMID: 11927172     DOI: 10.1016/S0893-133X(01)00367-0

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  243 in total

Review 1.  Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability.

Authors:  R Andrew Chambers; Jane R Taylor; Marc N Potenza
Journal:  Am J Psychiatry       Date:  2003-06       Impact factor: 18.112

2.  CHRNB2 promoter region: association with subjective effects to nicotine and gene expression differences.

Authors:  N R Hoft; J A Stitzel; K E Hutchison; M A Ehringer
Journal:  Genes Brain Behav       Date:  2010-11-04       Impact factor: 3.449

3.  Adolescent gambling: research and clinical implications.

Authors:  Mary K Wilber; Marc N Potenza
Journal:  Psychiatry (Edgmont)       Date:  2006-10

4.  Probability and predictors of remission from life-time nicotine, alcohol, cannabis or cocaine dependence: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Catalina Lopez-Quintero; Deborah S Hasin; José Pérez de Los Cobos; Abigail Pines; Shuai Wang; Bridget F Grant; Carlos Blanco
Journal:  Addiction       Date:  2010-11-16       Impact factor: 6.526

Review 5.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

6.  Linking Patterns of Substance Use With Sexual Risk-Taking Among Female Adolescents With and Without Histories of Maltreatment.

Authors:  Peter M Rivera; Bethany C Bray; Kate Guastaferro; Kari Kugler; Jennie G Noll
Journal:  J Adolesc Health       Date:  2018-02-01       Impact factor: 5.012

7.  Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.

Authors:  Robert Miranda; Hayley Treloar
Journal:  Curr Addict Rep       Date:  2016-04-02

8.  Developmentally divergent effects of Rho-kinase inhibition on cocaine- and BDNF-induced behavioral plasticity.

Authors:  Lauren M DePoy; Benjamin Noble; Amanda G Allen; Shannon L Gourley
Journal:  Behav Brain Res       Date:  2013-01-14       Impact factor: 3.332

9.  Epidemiological estimates of risk in the process of becoming dependent upon cocaine: cocaine hydrochloride powder versus crack cocaine.

Authors:  Chuan-Yu Chen; James C Anthony
Journal:  Psychopharmacology (Berl)       Date:  2003-11-04       Impact factor: 4.530

10.  Increased breakpoints on a progressive ratio schedule reinforced by IV cocaine are associated with reduced locomotor activation and reduced dopamine efflux in nucleus accumbens shell in rats.

Authors:  Christopher M Lack; Sara R Jones; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2007-09-19       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.